Recipient tissue microenvironment determines developmental path of intestinal innate lymphoid progenitors.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
06 Sep 2024
Historique:
received: 12 06 2023
accepted: 27 08 2024
medline: 7 9 2024
pubmed: 7 9 2024
entrez: 6 9 2024
Statut: epublish

Résumé

Innate lymphoid cells (ILCs) are critical in maintaining tissue homeostasis, and during infection and inflammation. Here we identify, by using combinatorial reporter mice, a rare ILC progenitor (ILCP) population, resident to the small intestinal lamina propria (siLP) in adult mice. Transfer of siLP-ILCP into recipients generates group 1 ILCs (including ILC1 and NK cells), ILC2s and ILC3s within the intestinal microenvironment, but almost exclusively group 1 ILCs in the liver, lung and spleen. Single cell gene expression analysis and high dimensional spectral cytometry analysis of the siLP-ILCPs and ILC progeny indicate that the phenotype of the group 1 ILC progeny is also influenced by the tissue microenvironment. Thus, a local pool of siLP-ILCP can contribute to pan-ILC generation in the intestinal microenvironment but has more restricted potential in other tissues, with a greater propensity than bone marrow-derived ILCPs to favour ILC1 and ILC3 production. Therefore, ILCP potential is influenced by both tissue of origin and the microenvironment during development. This may provide additional flexibility during the tuning of immune reactions.

Identifiants

pubmed: 39242588
doi: 10.1038/s41467-024-52155-2
pii: 10.1038/s41467-024-52155-2
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

7809

Subventions

Organisme : RCUK | Medical Research Council (MRC)
ID : U105178805
Organisme : Wellcome Trust (Wellcome)
ID : 100963/Z/13/Z
Organisme : Wellcome Trust (Wellcome)
ID : 220223/Z/20/Z
Organisme : EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 Marie Skłodowska-Curie Actions (H2020 Excellent Science - Marie Skłodowska-Curie Actions)
ID : 896454

Informations de copyright

© 2024. The Author(s).

Références

Colonna, M. Innate lymphoid cells: diversity, plasticity, and unique functions in immunity. Immunity 48, 1104–1117 (2018).
pubmed: 29924976 pmcid: 6344351 doi: 10.1016/j.immuni.2018.05.013
Eberl, G., Colonna, M., Di Santo, J. P. & McKenzie, A. N. Innate lymphoid cells. innate lymphoid cells: a new paradigm in immunology. Science 348, aaa6566 (2015).
pubmed: 25999512 pmcid: 5658207 doi: 10.1126/science.aaa6566
Vivier, E. et al. Innate lymphoid cells: 10 years on. Cell 174, 1054–1066 (2018).
pubmed: 30142344 doi: 10.1016/j.cell.2018.07.017
Xu, W. et al. An Id2(RFP)-reporter mouse redefines innate lymphoid cell precursor potentials. Immunity 50, 1054–1068.e1053 (2019).
pubmed: 30926235 pmcid: 6477155 doi: 10.1016/j.immuni.2019.02.022
Walker, J. A. et al. Polychromic reporter mice reveal unappreciated innate lymphoid cell progenitor heterogeneity and elusive ilc3 progenitors in bone marrow. Immunity 51, 104–118.e107 (2019).
pubmed: 31128961 pmcid: 6642165 doi: 10.1016/j.immuni.2019.05.002
Constantinides, M. G., McDonald, B. D., Verhoef, P. A. & Bendelac, A. A committed precursor to innate lymphoid cells. Nature 508, 397–401 (2014).
pubmed: 24509713 pmcid: 4003507 doi: 10.1038/nature13047
Ishizuka, I. E. et al. Single-cell analysis defines the divergence between the innate lymphoid cell lineage and lymphoid tissue-inducer cell lineage. Nat. Immunol. 17, 269–276 (2016).
pubmed: 26779601 pmcid: 4755916 doi: 10.1038/ni.3344
Yu, Y. et al. The transcription factor Bcl11b is specifically expressed in group 2 innate lymphoid cells and is essential for their development. J. Exp. Med 212, 865–874 (2015).
pubmed: 25964371 pmcid: 4451136 doi: 10.1084/jem.20142318
Yu, Y. et al. Single-cell RNA-seq identifies a PD-1(hi) ILC progenitor and defines its development pathway. Nature 539, 102–106 (2016).
pubmed: 27749818 doi: 10.1038/nature20105
Wong, S. H. et al. Transcription factor RORalpha is critical for nuocyte development. Nat. Immunol. 13, 229–236 (2012).
pubmed: 22267218 pmcid: 3343633 doi: 10.1038/ni.2208
Hoyler, T. et al. The transcription factor GATA-3 controls cell fate and maintenance of type 2 innate lymphoid cells. Immunity 37, 634–648 (2012).
pubmed: 23063333 pmcid: 3662874 doi: 10.1016/j.immuni.2012.06.020
Klose, C. S. N. et al. Differentiation of type 1 ILCs from a common progenitor to all helper-like innate lymphoid cell lineages. Cell 157, 340–356 (2014).
pubmed: 24725403 doi: 10.1016/j.cell.2014.03.030
Harly, C., Cam, M., Kaye, J. & Bhandoola, A. Development and differentiation of early innate lymphoid progenitors. J. Exp. Med 215, 249–262 (2018).
pubmed: 29183988 pmcid: 5748853 doi: 10.1084/jem.20170832
Zhong, C. et al. Differential expression of the transcription factor GATA3 specifies lineage and functions of innate lymphoid cells. Immunity 52, 83–95.e84 (2020).
pubmed: 31882362 doi: 10.1016/j.immuni.2019.12.001
Lim, A. I. et al. Systemic human ILC precursors provide a substrate for tissue ILC differentiation. Cell 168, 1086–1100 e1010 (2017).
pubmed: 28283063 doi: 10.1016/j.cell.2017.02.021
Liu, C. et al. Delineating spatiotemporal and hierarchical development of human fetal innate lymphoid cells. Cell Res 31, 1106–1122 (2021).
pubmed: 34239074 pmcid: 8486758 doi: 10.1038/s41422-021-00529-2
Suo, C. et al. Mapping the developing human immune system across organs. Science 376, eabo0510 (2022).
pubmed: 35549310 doi: 10.1126/science.abo0510
Chen, L. et al. CD56 expression marks human group 2 innate lymphoid cell divergence from a shared NK cell and group 3 innate lymphoid cell developmental pathway. Immunity 49, 464–476 e464 (2018).
pubmed: 30193847 pmcid: 6148384 doi: 10.1016/j.immuni.2018.08.010
Kokkinou, E. et al. CD45RA(+)CD62L(-) ILCs in human tissues represent a quiescent local reservoir for the generation of differentiated ILCs. Sci. Immunol. 7, eabj8301 (2022).
pubmed: 35427178 doi: 10.1126/sciimmunol.abj8301
Montaldo, E. et al. Human RORgammat(+)CD34(+) cells are lineage-specified progenitors of group 3 RORgammat(+) innate lymphoid cells. Immunity 41, 988–1000 (2014).
pubmed: 25500367 doi: 10.1016/j.immuni.2014.11.010
Scoville, S. D. et al. A progenitor cell expressing transcription factor rorgammat generates all human innate lymphoid cell subsets. Immunity 44, 1140–1150 (2016).
pubmed: 27178467 pmcid: 4893782 doi: 10.1016/j.immuni.2016.04.007
Chea, S. et al. Single-cell gene expression analyses reveal heterogeneous responsiveness of fetal innate lymphoid progenitors to notch signaling. Cell Rep. 14, 1500–1516 (2016).
pubmed: 26832410 doi: 10.1016/j.celrep.2016.01.015
Bando, J. K., Liang, H. E. & Locksley, R. M. Identification and distribution of developing innate lymphoid cells in the fetal mouse intestine. Nat. Immunol. 16, 153–160 (2015).
pubmed: 25501629 doi: 10.1038/ni.3057
Stehle, C. et al. T-bet and RORalpha control lymph node formation by regulating embryonic innate lymphoid cell differentiation. Nat. Immunol. 22, 1231–1244 (2021).
pubmed: 34556887 pmcid: 7614953 doi: 10.1038/s41590-021-01029-6
Simic, M. et al. Distinct waves from the hemogenic endothelium give rise to layered lymphoid tissue inducer cell ontogeny. Cell Rep. 32, 108004 (2020).
pubmed: 32783932 doi: 10.1016/j.celrep.2020.108004
Oherle, K. et al. Insulin-like growth factor 1 supports a pulmonary niche that promotes type 3 innate lymphoid cell development in newborn lungs. Immunity 52, 716–718 (2020).
pubmed: 32294410 pmcid: 7446937 doi: 10.1016/j.immuni.2020.03.018
Zeis, P. et al. In situ maturation and tissue adaptation of type 2 innate lymphoid cell progenitors. Immunity 53, 775–792.e779 (2020).
pubmed: 33002412 pmcid: 7611573 doi: 10.1016/j.immuni.2020.09.002
Ghaedi, M. et al. Single-cell analysis of RORalpha tracer mouse lung reveals ILC progenitors and effector ILC2 subsets. J Exp Med 217. https://doi.org/10.1084/jem.20182293 (2020).
Bai, L. et al. Liver type 1 innate lymphoid cells develop locally via an interferon-gamma-dependent loop. Science 371. https://doi.org/10.1126/science.aba4177 (2021).
Seillet, C. et al. Deciphering the Innate Lymphoid Cell Transcriptional Program. Cell Rep. 17, 436–447 (2016).
pubmed: 27705792 doi: 10.1016/j.celrep.2016.09.025
Sawa, S. et al. Lineage relationship analysis of RORgammat+ innate lymphoid cells. Science 330, 665–669 (2010).
pubmed: 20929731 doi: 10.1126/science.1194597
Walker, J. A. et al. Bcl11b is essential for group 2 innate lymphoid cell development. J. Exp. Med 212, 875–882 (2015).
pubmed: 25964370 pmcid: 4451131 doi: 10.1084/jem.20142224
Rodriguez-Rodriguez, N. et al. Identification of aceNKPs, a committed common progenitor population of the ILC1 and NK cell continuum. Proc. Natl Acad. Sci. USA 119, e2203454119 (2022).
pubmed: 36442116 pmcid: 7614094 doi: 10.1073/pnas.2203454119
Liu, Q., Lee, J. H., Kang, H. M. & Kim, C. H. Identification of the niche and mobilization mechanism for tissue-protective multipotential bone marrow ILC progenitors. Sci. Adv. 8, eabq1551 (2022).
pubmed: 36417511 pmcid: 9683709 doi: 10.1126/sciadv.abq1551
Anderson, K. G. et al. Intravascular staining for discrimination of vascular and tissue leukocytes. Nat. Protoc. 9, 209–222 (2014).
pubmed: 24385150 pmcid: 4428344 doi: 10.1038/nprot.2014.005
Mebius, R. E. & Kraal, G. Structure and function of the spleen. Nat. Rev. Immunol. 5, 606–616 (2005).
pubmed: 16056254 doi: 10.1038/nri1669
Gasteiger, G., Fan, X., Dikiy, S., Lee, S. Y. & Rudensky, A. Y. Tissue residency of innate lymphoid cells in lymphoid and nonlymphoid organs. Science 350, 981–985 (2015).
pubmed: 26472762 pmcid: 4720139 doi: 10.1126/science.aac9593
Paustian, A. M. S. et al. Continuous IL-23 stimulation drives ILC3 depletion in the upper GI tract and, in combination with TNFalpha, induces robust activation and a phenotypic switch of ILC3. PLoS One 12, e0182841 (2017).
pubmed: 28792532 pmcid: 5549730 doi: 10.1371/journal.pone.0182841
Martin, C. E. et al. Interleukin-7 availability is maintained by a hematopoietic cytokine sink comprising innate lymphoid cells and T cells. Immunity 47, 171–182.e174 (2017).
pubmed: 28723549 doi: 10.1016/j.immuni.2017.07.005
van de Pavert, S. A. & Vivier, E. Differentiation and function of group 3 innate lymphoid cells, from embryo to adult. Int Immunol. 28, 35–42 (2016).
pubmed: 26374472 doi: 10.1093/intimm/dxv052
Vonarbourg, C. et al. Regulated expression of nuclear receptor RORgammat confers distinct functional fates to NK cell receptor-expressing RORgammat(+) innate lymphocytes. Immunity 33, 736–751 (2010).
pubmed: 21093318 pmcid: 3042726 doi: 10.1016/j.immuni.2010.10.017
Robinette, M. L. et al. Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets. Nat. Immunol. 16, 306–317 (2015).
pubmed: 25621825 pmcid: 4372143 doi: 10.1038/ni.3094
Gury-BenAri, M. et al. The spectrum and regulatory landscape of intestinal innate lymphoid cells are shaped by the microbiome. Cell 166, 1231–1246 e1213 (2016).
pubmed: 27545347 doi: 10.1016/j.cell.2016.07.043
McFarland, A. P. et al. Multi-tissue single-cell analysis deconstructs the complex programs of mouse natural killer and type 1 innate lymphoid cells in tissues and circulation. Immunity 54, 1320–1337.e1324 (2021).
pubmed: 33945787 pmcid: 8312473 doi: 10.1016/j.immuni.2021.03.024
Cortez, V. S. et al. Transforming growth factor-beta signaling guides the differentiation of innate lymphoid cells in salivary glands. Immunity 44, 1127–1139 (2016).
pubmed: 27156386 pmcid: 5114145 doi: 10.1016/j.immuni.2016.03.007
Daussy, C. et al. T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow. J. Exp. Med 211, 563–577 (2014).
pubmed: 24516120 pmcid: 3949572 doi: 10.1084/jem.20131560
Dean, I. et al. Rapid functional impairment of natural killer cells following tumor entry limits anti-tumor immunity. Nat. Commun. 15, 683 (2024).
pubmed: 38267402 pmcid: 10808449 doi: 10.1038/s41467-024-44789-z
Schuster, I. S. et al. Infection induces tissue-resident memory NK cells that safeguard tissue health. Immunity 56, 2173–2174 (2023).
pubmed: 37703831 doi: 10.1016/j.immuni.2023.08.004
Torcellan, T. et al. Circulating NK cells establish tissue residency upon acute infection of skin and mediate accelerated effector responses to secondary infection. Immunity 57, 124–140.e127 (2024).
pubmed: 38157853 pmcid: 10783803 doi: 10.1016/j.immuni.2023.11.018
Seillet, C., Brossay, L. & Vivier, E. Natural killers or ILC1s? That is the question. Curr. Opin. Immunol. 68, 48–53 (2021).
pubmed: 33069142 doi: 10.1016/j.coi.2020.08.009
Lopes, N. et al. Tissue-specific transcriptional profiles and heterogeneity of natural killer cells and group 1 innate lymphoid cells. Cell Rep. Med 3, 100812 (2022).
pubmed: 36384102 pmcid: 9729827 doi: 10.1016/j.xcrm.2022.100812
Yang, Q. et al. TCF-1 upregulation identifies early innate lymphoid progenitors in the bone marrow. Nat. Immunol. 16, 1044–1050 (2015).
pubmed: 26280998 pmcid: 4575643 doi: 10.1038/ni.3248
Yu, X. et al. The basic leucine zipper transcription factor NFIL3 directs the development of a common innate lymphoid cell precursor. Elife 3. https://doi.org/10.7554/eLife.04406 (2014).
Haas, S., Trumpp, A. & Milsom, M. D. Causes and consequences of hematopoietic stem cell heterogeneity. Cell Stem Cell 22, 627–638 (2018).
pubmed: 29727678 doi: 10.1016/j.stem.2018.04.003
Schneider, C. et al. Tissue-resident group 2 innate lymphoid cells differentiate by layered ontogeny and in situ perinatal priming. Immunity 50, 1425–1438.e1425 (2019).
pubmed: 31128962 pmcid: 6645687 doi: 10.1016/j.immuni.2019.04.019
Liang, Z. et al. Eomes expression identifies the early bone marrow precursor to classical NK cells. Nat Immunol (2024).
Ding, Y. et al. Distinct developmental pathways generate functionally distinct populations of natural killer cells. Nat Immunol (2024).
Jowett, G. M. et al. Organoids capture tissue-specific innate lymphoid cell development in mice and humans. Cell Rep. 40, 111281 (2022).
pubmed: 36044863 pmcid: 9638027 doi: 10.1016/j.celrep.2022.111281
Spencer, S. P. et al. Adaptation of innate lymphoid cells to a micronutrient deficiency promotes type 2 barrier immunity. Science 343, 432–437 (2014).
pubmed: 24458645 pmcid: 4313730 doi: 10.1126/science.1247606
Li, P. et al. Reprogramming of T cells to natural killer-like cells upon Bcl11b deletion. Science 329, 85–89 (2010).
pubmed: 20538915 pmcid: 3628452 doi: 10.1126/science.1188063
Weber, L. M. & Robinson, M. D. Comparison of clustering methods for high-dimensional single-cell flow and mass cytometry data. Cytom. A 89, 1084–1096 (2016).
doi: 10.1002/cyto.a.23030
Van Gassen, S. et al. FlowSOM: Using self-organizing maps for visualization and interpretation of cytometry data. Cytom. A 87, 636–645 (2015).
doi: 10.1002/cyto.a.22625
Levine, J. H. et al. Data-driven phenotypic dissection of AML reveals progenitor-like cells that correlate with prognosis. Cell 162, 184–197 (2015).
pubmed: 26095251 pmcid: 4508757 doi: 10.1016/j.cell.2015.05.047
Nakano, T., Kodama, H. & Honjo, T. Generation of lymphohematopoietic cells from embryonic stem cells in culture. Science 265, 1098–1101 (1994).
pubmed: 8066449 doi: 10.1126/science.8066449
Zuniga-Pflucker, J. C. T-cell development made simple. Nat. Rev. Immunol. 4, 67–72 (2004).
pubmed: 14704769 doi: 10.1038/nri1257

Auteurs

Paula A Clark (PA)

MRC Laboratory of Molecular Biology, Cambridge, United Kingdom. pclark@mrc-lmb.cam.ac.uk.

Mayuri Gogoi (M)

MRC Laboratory of Molecular Biology, Cambridge, United Kingdom.

Noe Rodriguez-Rodriguez (N)

MRC Laboratory of Molecular Biology, Cambridge, United Kingdom.

Ana C F Ferreira (ACF)

MRC Laboratory of Molecular Biology, Cambridge, United Kingdom.

Jane E Murphy (JE)

MRC Laboratory of Molecular Biology, Cambridge, United Kingdom.

Jennifer A Walker (JA)

MRC Laboratory of Molecular Biology, Cambridge, United Kingdom.

Alastair Crisp (A)

MRC Laboratory of Molecular Biology, Cambridge, United Kingdom.

Helen E Jolin (HE)

MRC Laboratory of Molecular Biology, Cambridge, United Kingdom.

Jacqueline D Shields (JD)

Translational Medical Sciences, School of Medicine, University of Nottingham Biodiscovery Institute, Nottingham, United Kingdom.

Andrew N J McKenzie (ANJ)

MRC Laboratory of Molecular Biology, Cambridge, United Kingdom. anm@mrc-lmb.cam.ac.uk.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH